A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil

Obstet Gynecol Surv. 1985 Apr;40(4):190-220. doi: 10.1097/00006254-198504000-00002.
No abstract available

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Administration, Topical
  • Adult
  • Anal Canal / pathology
  • Anus Neoplasms / drug therapy
  • Anus Neoplasms / pathology
  • Carcinoma / drug therapy
  • Carcinoma / pathology
  • Carcinoma in Situ / drug therapy
  • Carcinoma in Situ / pathology
  • Carcinoma, Basal Cell / drug therapy
  • Carcinoma, Basal Cell / pathology
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology
  • Cervix Uteri / pathology
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / pharmacology
  • Fluorouracil / therapeutic use*
  • Genital Neoplasms, Female / drug therapy*
  • Genital Neoplasms, Female / pathology
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / congenital
  • Keratosis / drug therapy
  • Keratosis / pathology
  • Neoplasms, Multiple Primary / drug therapy
  • Neoplasms, Multiple Primary / pathology
  • Paget Disease, Extramammary / drug therapy
  • Skin / pathology
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Syndrome
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / pathology
  • Vagina / pathology
  • Vaginal Neoplasms / drug therapy
  • Vaginal Neoplasms / pathology
  • Vulva / pathology
  • Vulvar Neoplasms / drug therapy
  • Vulvar Neoplasms / pathology

Substances

  • Fluorouracil